glp-1 dietitian Patient Education Kit for Dietitians | Editable Canva Handouts | Semaglutide Sarcopenia Client Resources 💉 GLP-1 meds don't just

A population-based study of 467 matched pairs of GLP-1 users and non-users with type 2 diabetes and liver cirrhosis found GLP-1 use associated with lower risks of death, cardiovascular events, decompensated cirrhosis, hepatic encephalopathy, and liver failure

Interested in finding a way to offset glucagon's effect in raising blood sugar, the two researchers wondered if it was possible to create a dual agonist drug that targeted both GLP-1 and glucagon receptors

Elevate Health itself does not provide medical care or pharmacy services

verify terms on the providers site

After propensity-score matching, the two cohorts (241 in each cohort, mean age 51.8 years, 39.0% women, 32.6% black, 44.4% white, 5.8% Hispanic) were balanced (see Supplementary Table S3 in the Supplementary Appendix)

Typically, if the HbA1c remains 7.0% after a 3-month treatment period with adequate oral hypoglycemic drugs, initiation of insulin therapy may be considered